LallaRV, BowenJ, BaraschA, et al.; Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO). MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer, 2014; 120:1453–1461.
2.
BensadounRJ, NairRG. Low-level laser therapy in the management of mucositis and dermatitis induced by cancer therapy. Photomed Laser Surg, 2015; 33:487–491.
3.
ZechaJA, Raber-DurlacherJE, NairRG, et al.Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocols. Support Care Cancer, 2016; 24:2793–2805.
SonisST, HashemiS, EpsteinJB, NairRG, Raber-DurlacherJE. Could the biological robustness of low level laser therapy (Photobiomodulation) impact its use in the management of mucositis in head and neck cancer patients. Oral Oncol, 2016; 54:7–14.
